1. WHO should collaborate with Member States to strengthen the technical expertise of national control authorities in the regulation of plasma products, especially those countries with plasma fractionation activities or facilities to assure adequate quality, safety and efficacy of plasma products. This includes special emphasis on viral testing, viral inactivation procedures, and surveillance for viral and other transfusion transmitted diseases.
2. WHO should promote the regulation of blood bank facilities by National Control Authorities in order to ensure compliance with GMP principles.
3. WHO should facilitate the development of educational programs and training opportunities for National Control Authorities involved in regulation and control of blood products. WHO should promote regional cooperation and training.
4. WHO should assist Member States in the development of appropriate guidelines for plasma fractionation contract activities.
5. WHO should provide guidelines on information to be included in batch release certificates in order to facilitate acceptance of imported plasma products by national control authorities.